Search
COPD Clinical Trials in Charlotte,
A listing of COPD clinical trials in Charlotte, actively recruiting patient volunteers.
1 - 3 of 3
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
COPD
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Featured Trial
CMV Vaccine Trial For Young Women Ages 16-17
Recruiting
A Cytomegalovirus (CMV) Investigational Vaccine Clinical Trial for Healthy Women Age 16 to 17 years old. Compensation included.
Conditions:
Healthy Volunteers
Healthy
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Paid Vaccine Study For Teens
Recruiting
Vaccine study that aims to protect teens ages 12–17 against Epstein-Barr virus (EBV) and infectious mononucleosis (mono).
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Adult Migraine Study
Recruiting
Migraine study for adults. You may be compensated up to $800 for your time and travel expenses.
Conditions:
Headache
Cluster Headache
Headache Disorders
Post-Traumatic Headache
Migraine
Menstrual Migraine
Classic Migraine
Migraine
With or Without Aura
* Compensation for time may be available
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Recruiting
The purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab Dose 1 and Dose 2 administered subcutaneously (SC) in adult participants with symptomatic COPD and history of ≥ 2 moderate or ≥ 1 severe exacerbation of COPD in the previous 12 months. Participants should be receiving optimised treatment with maintenance inhaled therapy (ICS/LABA/LAMA triple therapy, or dual therapy if triple is not considered appropriate) in stable doses throughout at least 3 months prior... Read More
The purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab Dose 1 and Dose 2 administered subcutaneously (SC) in adult participants with symptomatic COPD and history of ≥ 2 moderate or ≥ 1 severe exacerbation of COPD in the previous 12 months. Participants should be receiving optimised treatment with maintenance inhaled therapy (ICS/LABA/LAMA triple therapy, or dual therapy if triple is not considered appropriate) in stable doses throughout at least 3 months prior to enrolment. Read Less
Gender:
All
Ages:
Between 40 years and 130 years
Locations: Research Site, Charlotte, North Carolina +272 locations
Research Site, Huntsville, Alabama
Research Site, Mobile, Alabama
Research Site, Montgomery, Alabama
Research Site, Tempe, Arizona
Research Site, Bakersfield, California
Research Site, Palm Springs, California
Research Site, Sacramento, California
Research Site, Boynton Beach, Florida
Research Site, Jacksonville, Florida
Research Site, Kissimmee, Florida
Research Site, Ormond Beach, Florida
Research Site, Plantation, Florida
Research Site, Brookhaven, Georgia
Research Site, Meridian, Idaho
Research Site, Chicago, Illinois
Research Site, Evanston, Illinois
Research Site, Evergreen Park, Illinois
Research Site, Normal, Illinois
Research Site, Iowa City, Iowa
Research Site, Kansas City, Kansas
Research Site, Baton Rouge, Louisiana
Research Site, Zachary, Louisiana
Research Site, Baltimore, Maryland
Research Site, Rochester, Minnesota
Research Site, Saint Louis, Missouri
Research Site, Saint Louis, Missouri
Research Site, Missoula, Montana
Research Site, Brick, New Jersey
Research Site, Guttenberg, New Jersey
Research Site, Albuquerque, New Mexico
Research Site, Bronx, New York
Research Site, Buffalo, New York
Research Site, New Hyde Park, New York
Research Site, New York, New York
Research Site, North Massapequa, New York
Research Site, Schenectady, New York
Research Site, Charlotte, North Carolina
Research Site, Durham, North Carolina
Research Site, Gastonia, North Carolina
Research Site, Raleigh, North Carolina
Research Site, Fargo, North Dakota
Research Site, DuBois, Pennsylvania
Research Site, Hershey, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Sayre, Pennsylvania
Research Site, Rapid City, South Dakota
Research Site, Franklin, Tennessee
Research Site, Nashville, Tennessee
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Kingwood, Texas
Research Site, Sherman, Texas
Research Site, Salt Lake City, Utah
Research Site, Burlington, Vermont
Research Site, Tacoma, Washington
Research Site, Charleston, West Virginia
Research Site, Marshfield, Wisconsin
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, Córdoba, Not set
Research Site, Florencio Varela, Not set
Research Site, Mar del Plata, Not set
Research Site, Mar del Plata, Not set
Research Site, Mendoza, Not set
Research Site, Quilmes, Not set
Research Site, Ranelagh, Not set
Research Site, San Fernando, Not set
Research Site, Tucumán, Not set
Research Site, Bruxelles, Not set
Research Site, Gent, Not set
Research Site, Leuven, Not set
Research Site, Liege, Not set
Research Site, Namur, Not set
Research Site, Dupnitsa, Not set
Research Site, Haskovo, Not set
Research Site, Kozloduy, Not set
Research Site, Lovech, Not set
Research Site, Petrich, Not set
Research Site, Pleven, Not set
Research Site, Ruse, Not set
Research Site, Sliven, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Troyan, Not set
Research Site, Varna, Not set
Research Site, Vratsa, Not set
Research Site, Calgary, Alberta
Research Site, Edmonton, Alberta
Research Site, Sherwood Park, Alberta
Research Site, Kamloops, British Columbia
Research Site, Kelowna, British Columbia
Research Site, Ajax, Ontario
Research Site, Barrie, Ontario
Research Site, Guelph, Ontario
Research Site, Hamilton, Ontario
Research Site, Markham, Ontario
Research Site, Stouffville, Ontario
Research Site, Winchester, Ontario
Research Site, Montreal, PQ
Research Site, Terrebonne, Quebec
Research Site, Quebec, Not set
Research Site, Quebec, Not set
Research Site, Brno, Not set
Research Site, Broumov, Not set
Research Site, Jihlava, Not set
Research Site, Jindrichuv Hradec, Not set
Research Site, Liberec 1, Not set
Research Site, Mlada Boleslav, Not set
Research Site, Olomouc, Not set
Research Site, Rokycany, Not set
Research Site, Aarhus, Not set
Research Site, Hvidovre, Not set
Research Site, København NV, Not set
Research Site, Næstved, Not set
Research Site, Roskilde, Not set
Research Site, Vejle, Not set
Research Site, Ålborg, Not set
Research Site, Helsinki, Not set
Research Site, Hämeenlinna, Not set
Research Site, Kuopio, Not set
Research Site, Tampere, Not set
Research Site, Turku, Not set
Research Site, Turku, Not set
Research Site, Baja, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Encs, Not set
Research Site, Gyöngyös, Not set
Research Site, Mosonmagyaróvár, Not set
Research Site, Százhalombatta, Not set
Research Site, Székesfehérvár, Not set
Research Site, Ahmedabad, Not set
Research Site, Belagavi, Not set
Research Site, Coimbatore, Not set
Research Site, Dehradun, Not set
Research Site, Jaipur, Not set
Research Site, Kolkatta, Not set
Research Site, Mohali, Not set
Research Site, Nagpur, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, New Delhi, Not set
Research Site, Thane, Not set
Research Site, Asahikawa-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chikushino-shi, Not set
Research Site, Chuo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fujieda-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Hamamatsu-shi, Not set
Research Site, Hamamatsu-shi, Not set
Research Site, Himeji-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Iizuka-shi, Not set
Research Site, Itabashi-ku, Not set
Research Site, Iwata-shi, Not set
Research Site, Izumi-shi, Not set
Research Site, Joyo-shi, Not set
Research Site, Kagoshima-shi, Not set
Research Site, Kakogawa-shi, Not set
Research Site, Kamogawa-shi, Not set
Research Site, Kanazawa-shi, Not set
Research Site, Kanazawa-shi, Not set
Research Site, Kawachinagano-shi, Not set
Research Site, Kitakyusyu-shi, Not set
Research Site, Kitakyusyu, Not set
Research Site, Kiyose-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Kofu-shi, Not set
Research Site, Koga-shi, Not set
Research Site, Kokubunji-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Matsusaka-shi, Not set
Research Site, Meguro-ku, Not set
Research Site, Mitaka-shi, Not set
Research Site, Miyazaki-shi, Not set
Research Site, Mizunami-shi, Not set
Research Site, Nagaoka-shi, Not set
Research Site, Nagaoka-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Narita-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Nishinomiya-shi, Not set
Research Site, Obihiro, Not set
Research Site, Okayama-shi, Not set
Research Site, Okayama, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Sakai-shi, Not set
Research Site, Sakaide-shi, Not set
Research Site, Saku-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sendai-Shi, Not set
Research Site, Seto-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Shizuoka-shi, Not set
Research Site, Tachikawa-shi, Not set
Research Site, Takamatsu-shi, Not set
Research Site, Toshima-ku, Not set
Research Site, Toyama-shi, Not set
Research Site, Toyonaka-shi, Not set
Research Site, Wakayama-shi, Not set
Research Site, Yamagata-shi, Not set
Research Site, Yanagawa-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Daegu, Not set
Research Site, Incheon, Not set
Research Site, Jeonju-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Benito Juarez, Not set
Research Site, Chihuahua, Not set
Research Site, Guadalajara, Not set
Research Site, Guadalajara, Not set
Research Site, Mexico City, Not set
Research Site, Monterrey, Not set
Research Site, Morelia, Not set
Research Site, Mérida, Not set
Research Site, Oaxaca, Not set
Research Site, Veracruz, Not set
Research Site, Alkmaar, Not set
Research Site, Eindhoven, Not set
Research Site, Groningen, Not set
Research Site, Harderwijk, Not set
Research Site, Heerlen, Not set
Research Site, Zutphen, Not set
Research Site, Zwolle, Not set
Research Site, Bergen, Not set
Research Site, Bodø, Not set
Research Site, Levanger, Not set
Research Site, Lørenskog, Not set
Research Site, Oslo, Not set
Research Site, Tønsberg, Not set
Research Site, Ålesund, Not set
Research Site, Lisboa, Not set
Research Site, Lisboa, Not set
Research Site, Matosinhos, Not set
Research Site, Vila Nova de Gaia, Not set
Research Site, Guaynabo, Not set
Research Site, San Juan, Not set
Research Site, Galdakao, Not set
Research Site, Madrid, Not set
Research Site, Malaga, Not set
Research Site, Mérida, Not set
Research Site, Pozuelo de Alarcon, Not set
Research Site, Santander, Not set
Research Site, Valencia, Not set
Research Site, Zaragoza, Not set
Research Site, Göteborg, Not set
Research Site, Lund, Not set
Research Site, Malmö, Not set
Research Site, Stockholm, Not set
Research Site, Örebro, Not set
Research Site, Ankara, Not set
Research Site, Aydin, Not set
Research Site, Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Research Site, Mersin, Not set
Research Site, Hanoi, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh, Not set
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Recruiting
This is a 12-week (with an extension to 52 weeks in a subset of participants) study comparing the safety of BGF MDI HFO twice daily (BID) with BGF MDI HFA BID in participants with moderate to very severe COPD.
This is a 12-week (with an extension to 52 weeks in a subset of participants) study comparing the safety of BGF MDI HFO twice daily (BID) with BGF MDI HFA BID in participants with moderate to very severe COPD. Read Less
Gender:
All
Ages:
Between 40 years and 80 years
Locations: Research Site, Charlotte, North Carolina +96 locations
Research Site, Phoenix, Arizona
Research Site, Newport Beach, California
Research Site, Miami, Florida
Research Site, Sarasota, Florida
Research Site, Tampa, Florida
Research Site, Valparaiso, Indiana
Research Site, Crowley, Louisiana
Research Site, North Dartmouth, Massachusetts
Research Site, Saint Louis, Missouri
Research Site, Charlotte, North Carolina
Research Site, Wilmington, North Carolina
Research Site, Dublin, Ohio
Research Site, Grants Pass, Oregon
Research Site, Portland, Oregon
Research Site, Anderson, South Carolina
Research Site, Columbia, South Carolina
Research Site, Gaffney, South Carolina
Research Site, Longview, Texas
Research Site, McKinney, Texas
Research Site, Richmond, Virginia
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Quilmes, Not set
Research Site, Rosario, Not set
Research Site, San Fernando, Not set
Research Site, Blagoevgrad, Not set
Research Site, Dupnitsa, Not set
Research Site, Lom, Not set
Research Site, Pernik, Not set
Research Site, Sandanski, Not set
Research Site, Sevlievo, Not set
Research Site, Sofia, Not set
Research Site, Veliko Tarnovo, Not set
Research Site, Vidin, Not set
Research Site, Moncton, New Brunswick
Research Site, Truro, Nova Scotia
Research Site, Ajax, Ontario
Research Site, Burlington, Ontario
Research Site, Guelph, Ontario
Research Site, Mississauga, Ontario
Research Site, Montreal, Quebec
Research Site, St Charles Borromee, Quebec
Research Site, Trois-Rivières, Quebec
Research Site, Quebec, Not set
Research Site, Quebec, Not set
Research Site, Quebec, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Dresden, Not set
Research Site, Elsterwerda, Not set
Research Site, Essen, Not set
Research Site, Halle, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Karlsruhe, Not set
Research Site, Koblenz, Not set
Research Site, Magdeburg, Not set
Research Site, Rheine, Not set
Research Site, Schwerin, Not set
Research Site, Wiesbaden, Not set
Research Site, Witten, Not set
Research Site, Cuernavaca, Not set
Research Site, Culiacán, Not set
Research Site, Guadalajara, Not set
Research Site, Merida, Not set
Research Site, Mexico City, Not set
Research Site, Monterrey, Not set
Research Site, México, Not set
Research Site, Bydgoszcz, Not set
Research Site, Bydgoszcz, Not set
Research Site, Będzin, Not set
Research Site, Grodzisk Mazowiecki, Not set
Research Site, Inowrocław, Not set
Research Site, Jelenia Góra, Not set
Research Site, Kraków, Not set
Research Site, Lublin, Not set
Research Site, Piaseczno, Not set
Research Site, Skórzewo, Not set
Research Site, Szczecin, Not set
Research Site, Zamość, Not set
Research Site, Łódź, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Research Site, Izmir, Not set
Research Site, Mersin, Not set
Research Site, Pamukkale, Not set
Research Site, Blackpool, Not set
Research Site, Corby, Not set
Research Site, Liverpool, Not set
Research Site, Poole, Not set
Research Site, Thetford, Not set
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
Recruiting
The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population.
The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population. Read Less
Gender:
All
Ages:
40 years and above
Locations: Chiesi Clinical Trial Site 840215, Charlotte, North Carolina +236 locations
Chiesi Clinical Trial Site 840186, Dothan, Alabama
Chiesi Clinical Trial Site 840258, Foley, Alabama
Chiesi Clinical Trial Site 840279, Jasper, Alabama
Chiesi Clinical Trial Site 840206, Montgomery, Alabama
Chiesi Clinical Trial Site 840190, Phoenix, Arizona
Chiesi Clinical Trial Site 840209, Escondido, California
Chiesi Clinical Trial Site 840144, Fountain Valley, California
Chiesi Clinical Trial Site 840173, Newport Beach, California
Chiesi Clinical Trial Site 840208, Northridge, California
Chiesi Clinical Trial Site 840226, Sacramento, California
Chiesi Clinical Trial Site 840107, San Diego, California
Chiesi Clinical Trial Site 840164, Upland, California
Chiesi Clinical Trial Site 840174, West Covina, California
Chiesi Clinical Trial Site 840229, Boulder, Colorado
Chiesi Clinical Trial Site 840268, Aventura, Florida
Chiesi Clinical Trial Site 840192, Brandon, Florida
Chiesi Clinical Trial Site 840240, Chiefland, Florida
Chiesi Clinical Trial Site 840153, Clearwater, Florida
Chiesi Clinical Trial Site 840272, Coral Gables, Florida
Chiesi Clinical Trial Site 840304, Coral Gables, Florida
Chiesi Clinical Trial Site 840141, Daytona Beach, Florida
Chiesi Clinical Trial Site 840133, DeLand, Florida
Chiesi Clinical Trial Site 840303, Hialeah, Florida
Chiesi Clinical Trial Site 840163, Hialeah, Florida
Chiesi Clinical Trial Site 840165, Hialeah, Florida
Chiesi Clinical Trial Site 840238, Hialeah, Florida
Chiesi Clinical Trial Site 840241, Hialeah, Florida
Chiesi Clinical Trial Site 840253, Hialeah, Florida
Chiesi Clinical Trial Site 840184, Hialeah, Florida
Chiesi Clinical Trial Site 840267, Hialeah, Florida
Chiesi Clinical Trial Site 840200, Kissimmee, Florida
Chiesi Clinical Trial Site 840232, Lakeland, Florida
Chiesi Clinical Trial Site 840288, Miami Lakes, Florida
Chiesi Clinical Trial Site 840137, Miami, Florida
Chiesi Clinical Trial Site 840180, Miami, Florida
Chiesi Clinical Trial Site 840175, Miami, Florida
Chiesi Clinical Trial Site 840205, Miami, Florida
Chiesi Clinical Trial Site 840247, Miami, Florida
Chiesi Clinical Trial Site 840148, Miami, Florida
Chiesi Clinical Trial Site 840193, Miami, Florida
Chiesi Clinical Trial Site 840239, Miami, Florida
Chiesi Clinical Trial Site 840237, Miami, Florida
Chiesi Clinical Trial Site 840261, Miami, Florida
Chiesi Clinical Trial Site 840262, Miami, Florida
Chiesi Clinical Trial Site 840280, Miami, Florida
Chiesi Clinical Trial Site 840178, Miami, Florida
Chiesi Clinical Trial Site 840202, Miami, Florida
Chiesi Clinical Trial Site 840275, Miami, Florida
Chiesi Clinical Trial Site 840122, Miami, Florida
Chiesi Clinical Trial Site 840235, Miami, Florida
Chiesi Clinical Trial Site 840243, Miami, Florida
Chiesi Clinical Trial Site 840244, Miami, Florida
Chiesi Clinical Trial Site 840257, Miami, Florida
Chiesi Clinical Trial Site 840162, Miami, Florida
Chiesi Clinical Trial Site 840166, Miami, Florida
Chiesi Clinical Trial Site 840140, Mount Dora, Florida
Chiesi Clinical Trial Site 840263, New Port Richey, Florida
Chiesi Clinical Trial Site 840161, North Miami Beach, Florida
Chiesi Clinical Trial Site 840132, North Miami, Florida
Chiesi Clinical Trial Site 840255, Orlando, Florida
Chiesi Clinical Trial Site 840110, Orlando, Florida
Chiesi Clinical Trial Site 840125, Orlando, Florida
Chiesi Clinical Trial Site 840121, Palmetto Bay, Florida
Chiesi Clinical Trial Site 840196, Pembroke Pines, Florida
Chiesi Clinical Trial Site 840198, Pembroke Pines, Florida
Chiesi Clinical Trial Site 840252, Pompano Beach, Florida
Chiesi Clinical Trial Site 840291, Saint Petersburg, Florida
Chiesi Clinical Trial Site 840290, Saint Petersburg, Florida
Chiesi Clinical Trial Site 840131, Tampa, Florida
Chiesi Clinical Trial Site 840309, Tampa, Florida
Chiesi Clinical Trial Site 840210, The Villages, Florida
Chiesi Clinical Trial Site 840256, Virginia Gardens, Florida
Chiesi Clinical Trial Site 840223, Adairsville, Georgia
Chiesi Clinical Trial Site 840218, Columbus, Georgia
Chiesi Clinical Trial Site 840227, Lawrenceville, Georgia
Chiesi Clinical Trial Site 840138, Rincon, Georgia
Chiesi Clinical Trial Site 840207, Crowley, Louisiana
Chiesi Clinical Trial site 840250, North Dartmouth, Massachusetts
Chiesi Clinical Trial Site 840183, Farmington Hills, Michigan
Chiesi Clinical Trial Site 840287, Southfield, Michigan
Chiesi Clinical Trial Site 840278, Chesterfield, Missouri
Chiesi Clinical Trial Site 840155, Columbia, Missouri
Chiesi Clinical Trial Site 840150, Saint Charles, Missouri
Chiesi Clinical Trial Site 840282, Saint Louis, Missouri
Chiesi Clinical Trial Site 840123, Saint Louis, Missouri
Chiesi Clinical Trial Site 840142, Saint Louis, Missouri
Chiesi Clinical Trial Site 840273, Missoula, Montana
Chiesi Clinical Trial Site 840281, Lincoln, Nebraska
Chiesi Clinical Trial Site 840213, Las Vegas, Nevada
Chiesi Clinical Trial Site 840128, Bronx, New York
Chiesi Clinical Trial Site 840215, Charlotte, North Carolina
Chiesi Clinical Trial Site 840158, Charlotte, North Carolina
Chiesi Clinical Trial Site 840236, Huntersville, North Carolina
Chiesi Clinical Trial Site 840259, Monroe, North Carolina
Chiesi Clinical Trial Site 840194, New Bern, North Carolina
Chiesi Clinical Trial Site 840120, Raleigh, North Carolina
Chiesi Clinical Trial Site 840112, Rocky Mount, North Carolina
Chiesi Clinical Trial Site 840135, Shelby, North Carolina
Chiesi Clinical Trial Site 840189, Wilmington, North Carolina
Chiesi Clinical Trial Site 840104, Cincinnati, Ohio
Chiesi Clinical Trial Site 840124, Columbus, Ohio
Chiesi Clinical Trial Site 840233, Maumee, Ohio
Chiesi Clinical Trial Site 840157, Toledo, Ohio
Chiesi Clinical Trial Site 840203, Medford, Oregon
Chiesi Clinical Trial Site 840156, Jenkintown, Pennsylvania
Chiesi Clinical Trial Site 840222, Anderson, South Carolina
Chiesi Clinical Trial Site 840130, Columbia, South Carolina
Chiesi Clinical Trial Site 840211, Fort Mill, South Carolina
Chiesi Clinical Trial Site 840182, Gaffney, South Carolina
Chiesi Clinical Trial Site 840111, Greenville, South Carolina
Chiesi Clinical Trial Site 840100, Rock Hill, South Carolina
Chiesi Clinical Trial Site 840106, Union, South Carolina
Chiesi Clinical Trial Site 840167, Jackson, Tennessee
Chiesi Clinical Trial Site 840306, Johnson City, Tennessee
Chiesi Clinical Trial Site 840171, Knoxville, Tennessee
Chiesi Clinical Trial Site 840271, Tullahoma, Tennessee
Chiesi Clinical Trial Site 840101, Baytown, Texas
Chiesi Clinical Trial Site 840114, Boerne, Texas
Chiesi Clinical Trial Site 840146, Cypress, Texas
Chiesi Clinical Trial Site 840284, Houston, Texas
Chiesi Clinical Trial Site 840102, Katy, Texas
Chiesi Clinical Trial Site 840274, Katy, Texas
Chiesi Clinical Trial Site 840119, McKinney, Texas
Chiesi Clinical Trial Site 840176, North Richland Hills, Texas
Chiesi Clinical Trial Site 840191, San Antonio, Texas
Chiesi Clinical Trial Site 840231, Sherman, Texas
Chiesi Clinical Trial Site 840221, Sugar Land, Texas
Chiesi Clinical Trial Site 840139, Tomball, Texas
Chiesi Clinical Trial Site 840264, Manassas, Virginia
Chiesi Clinical Trial Site 840159, Richmond, Virginia
Chiesi Clinical Trial Site 840201, Morgantown, West Virginia
Chiesi Clinical Trial Site 032115, Ciudad Autonoma de Buenos Aire, Buenos Aires
Chiesi Clinical Trial Site 032113, Ciudad Autonoma de Buenos Aire, Buenos Aires
Chiesi Clinical Trial Site 032107, Ciudad Autonoma de Buenos Aire, Buenos Aires
Chiesi Clinical Trial Site 032112, Ciudad Autonoma de Buenos Aire, Buenos Aires
Chiesi Clinical Trial Site 032121, Ciudad Autonoma de Buenos Aire, Buenos Aires
Chiesi Clinical Trial Site 032110, Florencio Varela, Buenos Aires
Chiesi Clinical Trial Site 032108, La Plata, Buenos Aires
Chiesi Clinical Trial Site 032118, Mar Del Plata, Buenos Aires
Chiesi Clinical Trial Site 032114, Mar Del Plata, Buenos Aires
Chiesi Clinical Trial Site 032102, Monte Grande, Buenos Aires
Chiesi Clinical Trial Site 032106, Quilmes, Buenos Aires
Chiesi Clinical Trial Site 032116, San Fernando, Buenos Aires
Chiesi Clinical Trial Site 032100, Vicente López, Buenos Aires
Chiesi Clinical Trial Site 032111, Córdoba, Cordoba
Chiesi Clinical Trial Site 032120, Concepción Del Uruguay, Entre Rios
Chiesi Clinical Trial Site 032101, Rosario, Santa Fe
Chiesi Clinical Trial Site 032117, Tucumán, Tucuman
Chiesi Clinical Trial Site 032103, Ciudad Autonoma de Buenos Aire, Not set
Chiesi Clinical Trial Site 032109, Ciudad Autonoma de Buenos Aire, Not set
Chiesi Clinical Trial Site 032105, Mendoza, Not set
Chiesi Clinical Trial Site 100125, Gabrovo, Not set
Chiesi Clinical Trial Site 100109, Haskovo, Not set
Chiesi Clinical Trial Site 100129, Kozloduy, Not set
Chiesi Clinical Trial Site 100111, Lovech, Not set
Chiesi Clinical Trial Site 100115, Montana, Not set
Chiesi Clinical Trial Site 100101, Pleven, Not set
Chiesi Clinical Trial Site 100102, Plovdiv, Not set
Chiesi Clinical Trial Site 100126, Plovdiv, Not set
Chiesi Clinical Trial Site 100128, Razgrad, Not set
Chiesi Clinical Trial Site 100104, Ruse, Not set
Chiesi Clinical Trial Site 100113, Ruse, Not set
Chiesi Clinical Trial Site 100100, Sofia, Not set
Chiesi Clinical Trial Site 100110, Sofia, Not set
Chiesi Clinical Trial Site 100112, Sofia, Not set
Chiesi Clinical Trial Site 100116, Sofia, Not set
Chiesi Clinical Trial Site 100117, Sofia, Not set
Chiesi Clinical Trial Site 100118, Sofia, Not set
Chiesi Clinical Trial Site 100119, Sofia, Not set
Chiesi Clinical Trial Site 100121, Sofia, Not set
Chiesi Clinical Trial Site 100123, Sofia, Not set
Chiesi Clinical Trial Site 100124, Sofia, Not set
Chiesi Clinical Trial Site 100127, Sofia, Not set
Chiesi Clinical Trial Site 100103, Stara Zagora, Not set
Chiesi Clinical Trial Site 100107, Stara Zagora, Not set
Chiesi Clinical Trial Site 100130, Varna, Not set
Chiesi Clinical Trial Site 100122, Veliko Tarnovo, Not set
Chiesi Clinical Trial Site 100106, Vidin, Not set
Chiesi Clinical Trial Site 100114, Vidin, Not set
Chiesi Clinical Trial Site 203101, Brandýs Nad Labem, Not set
Chiesi Clinical Trial Site 203107, Jindřichův Hradec, Not set
Chiesi Clinical Trial Site 203109, Miroslav, Not set
Chiesi Clinical Trial Site 203114, Praha, Not set
Chiesi Clinical Trial Site 203112, Rokycany, Not set
Chiesi Clinical Trial Site 203108, Strakonice, Not set
Chiesi Clinical Trial Site 203104, Teplice, Not set
Chiesi Clinical Trial Site 203105, Tábor, Not set
Chiesi Clinical Trial Site 203110, Varnsdorf, Not set
Chiesi Clinical Trial Site 348121, Komló, BA
Chiesi Clinical Trial Site 348122, Pécs, BA
Chiesi Clinical Trial Site 348108, Szarvas, Bekes
Chiesi Clinical Trial Site 348124, Csorna, GS
Chiesi Clinical Trial Site 348126, Szolnok, JN
Chiesi Clinical Trial Site 348107, Balassagyarmat, Nograd
Chiesi Clinical Trial Site 348120, Gödöllő, Pest
Chiesi Clinical Trial Site 348104, Nyiregyhaza, Szabolcs-Szatmar-Bereg
Chiesi Clinical Trial Site 348109, Nyiregyhaza, Szabolcs-Szatmár-Bereg
Chiesi Clinical Trial Site 348105, Szombathely, Vas
Chiesi Clinical Trial Site 348112, Hajdúnánás, Not set
Chiesi Clinical Trial Site 348116, Hatvan, Not set
Chiesi Clinical Trial Site 348103, Monor, Not set
Chiesi Clinical Trial Site 484110, Tijuana, Baja California
Chiesi Clinical Trial Site 484108, Ciudad de mexico, Cdmx
Chiesi Clinical Trial Site 484103, Cuauhtémoc, Cdmx
Chiesi Clinical Trial Site 484100, Guadalajara, Jalisco
Chiesi Clinical Trial Site 484102, Guadalajara, Jalisco
Chiesi Clinical Trial Site 484104, Guadalajara, Jalisco
Chiesi Clinical Trial Site 484106, Guadalajara, Jalisco
Chiesi Clinical Trial Site 484112, Guadalajara, Jalisco
Chiesi Clinical Trial Site 484107, Morelia, Michoacan
Chiesi Clinical Trial Site 484101, Monterrey, Nuevo Leon
Chiesi Clinical Trial Site 484111, Monterrey, Nuevo Leon
Chiesi Clinical Trial Site 484105, Chihuahua, Not set
Chiesi Clinical Trial Site 484109, Chihuahua, Not set
Chiesi Clinical Trial Site 616119, Białystok, Not set
Chiesi Clinical Trial Site 616100, Gizycko, Not set
Chiesi Clinical Trial Site 616113, Grudziądz, Not set
Chiesi Clinical Trial Site 616116, Katowice, Not set
Chiesi Clinical Trial Site 616122, Kraków, Not set
Chiesi Clinical Trial Site 616106, Kraków, Not set
Chiesi Clinical Trial Site 616109, Kraków, Not set
Chiesi Clinical Trial Site 616118, Kraków, Not set
Chiesi Clinical Trial Site 616117, Ostrowiec, Not set
Chiesi Clinical Trial Site 616105, Ostróda, Not set
Chiesi Clinical Trial Site 616123, Poznań, Not set
Chiesi Clinical Trial Site 616107, Poznań, Not set
Chiesi Clinical Trial Site 616110, Poznań, Not set
Chiesi Clinical Trial Site 616108, Rzeszów, Not set
Chiesi Clinical Trial Site 616114, Skierniewice, Not set
Chiesi Clinical Trial Site 616120, Skorzewo, Not set
Chiesi Clinical Trial Site 616102, Sosnowiec, Not set
Chiesi Clinical Trial Site 616111, Tarnów, Not set
Chiesi Clinical Trial Site 616115, Toruń, Not set
Chiesi Clinical Trial Site 616104, Wrocław, Not set
Chiesi Clinical Trial Site 616112, Wrocław, Not set
Chiesi Clinical Trial Site 616101, Zawadzkie, Not set
Chiesi Clinical Trial Site 616103, Łódź, Not set
Conditions: COPD, COPD Exacerbation
1 - 3 of 3